CHEK1 and acute lymphoblastic leukemia: A combination of olaparib and AZD1775 was synergistic against ALL cells in vitro (100) and a combination of the CHK1 inhibitor PF-0477736 with AZD1775 showed synergy against primary ALL samples (104).